HONOLULU — The investigational dopamine-1 (D1) receptor antagonist ecopipam (developed by Emalex Biosciences) is safe and effective for the improvement of Tourette syndrome (TS) symptoms in children, ...
TS symptoms typically begin between the ages of 4 and 7. These symptoms present in the form of tics, or sudden, rapid, ...
That's from a study by WeAreTechWomen & management consultants Oliver Wyman, which also found between 40,000 and 60,000 women ...